4.6 Article

National clinical practice guidelines for allergen immunotherapy: An international assessment applying AGREE-II

期刊

ALLERGY
卷 73, 期 3, 页码 664-672

出版社

WILEY
DOI: 10.1111/all.13316

关键词

AGREE II instrument; allergen immunotherapy; allergic rhinitis; subcutaneous immunotherapy; sublingual immunotherapy

资金

  1. Asthma UK [MRC-AsthmaUKCentre, MRC-Asthma UK Centre] Funding Source: researchfish
  2. Medical Research Council [G1000758B, G1000758] Funding Source: researchfish

向作者/读者索取更多资源

BackgroundSince 1988, numerous allergen immunotherapy guidelines (AIT-GLs) have been developed by national and international organizations to guide physicians in AIT. Even so, AIT is still severely underused. ObjectiveTo evaluate AIT-GLs with AGREE-II, developed in 2010 by McMaster University methodologists to comprehensively evaluate GL quality. MethodsAllergist, from different continents, knowledgeable in AIT and AGREE-II trained were selected into the project team. The project received methodologists' guidance. AIT-GLs in any language were sought from 1980 to 2016; AIT-GLs were AGREE II-evaluated by at least 2 team members, independently; discrepancies were resolved in a second round, by team discussion or methodologists' consulting. ResultsWe found 31 AIT-GLs (15 post-2010), ranging from local consensus reports to international position papers (EAACI, AAAAI-ACAAI, WAO). Pre-2010 GLs scored 1.6-4.6 (23%-67%) and post-2010 GLs scored 2.1-6 (30%-86%), on a 7-point Likert scale. The highest scores went to: German-Austrian-Swiss (6.0), Mexican (5.1), and the AAAAI/ACAAI AIT-GL (4.7). These were also the only 3 GLs that received yes of both evaluators to the item: I would recommend this GL for use. The domains of Stakeholder involvement and Rigor of Development only scored 3/7, and Applicability scored the lowest. Strikingly, newer GLs only scored clearly better in Editorial independence and Global evaluation. ConclusionsIn AIT-GLs, there is still a lot of room for improvement, especially in domains crucial for the dissemination. For some GLs, the Scientific rigor domain flawed. When resources are limited, transculturizing a high-quality GL might be preferable over developing a GL from zero. Our study and AGREE-II could help to select the best candidate. Clinical ImplicationsWe here evaluate allergen immunotherapy guideline (AIT-GL) quality. Only high-quality AIT-GLs should be consulted for AIT management decisions. In low-resource settings, transculturization of these is preferred over developing low-quality guidelines.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据